Companies: 10,795·Total market cap: $144.5T
Innovation1 Biotech Inc.

Innovation1 Biotech Inc.

IVBTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4494
P/E Ratio—
52W High$0.005
52W Low$0.0002
SEC Filings

Innovation1 Biotech Inc. (IVBT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001629205 · IVBT · OTC · as of Jun 8, 2026

Filing snapshot

164
Total Filings
10-Q
Latest Form
2025-05-06
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001629205 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-01-17
Fiscal Year End
Jan 17, 2024
Accession No.
0001477932-24-000223
Primary Document
ivbt_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001629205 · Accession 0001477932-24-000223

Latest Key Filings

10-QQuarterly Report
10-Q
2025-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2025-02-27Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2025-05-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-03-03
View
8-KCurrent Report
8-K
2025-02-27
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-02-04
View
10-QQuarterly Report
10-Q
2025-01-27
View
DEF 14CDEF 14C
DEF 14C
2025-01-27
View
PRE 14CPRE 14C
PRE 14C
2025-01-15
View
NT 10-QNT 10-Q
NT 10-Q
2024-01-17
View
10-KAnnual Report
FORM 10-K
2024-01-17
View
8-KCurrent Report
FORM 8-K
2023-12-13
View
NT 10-KNT 10-K
NT 10-K
2023-11-29
View
8-KCurrent Report
FORM 8-K
2023-11-07
View
8-KCurrent Report
FORM 8-K
2023-10-16
View
10-QQuarterly Report
FORM 10-Q
2023-09-13
View
8-KCurrent Report
FORM 8-K
2023-09-08
View
Showing 1–15 of 163 filingsForm 4 / 144 hidden· 164 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001629205  |  Exchange: OTC · Healthcare

Innovation1 Biotech Inc. (OTC: IVBT) has submitted 164 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001629205, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Innovation1 Biotech Inc.'s most comprehensive regulatory disclosure. The most recent Innovation1 Biotech Inc. 10-K was filed on 2024-01-17 for fiscal year ending 2024. Historical IVBT 10-K annual reports are available from 2015 through 2024.

Investors researching Innovation1 Biotech Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
AMPE SEC Filings →ARNI SEC Filings →BTTX SEC Filings →BXRXQ SEC Filings →KLDO SEC Filings →XENO SEC Filings →TNGNQ SEC Filings →CALA SEC Filings →
→ IVBT Financials→ IVBT Earnings→ IVBT Insider Trades

Frequently Asked Questions

IVBT SEC Filings · 8 questions

Innovation1 Biotech Inc. (IVBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 164 filings and access original documents at no cost. Innovation1 Biotech Inc.'s CIK is 0001629205.

IVBT SEC filingsInnovation1 Biotech Inc. SEC documentsfind IVBT 10-K